NPI: 1043293608 · BOWLING GREEN, KY 42101 · Early Intervention Provider Agency · NPI assigned 11/28/2005
Authorized official LAWLESS, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | LAWLESS, MICHELE (EXECUTIVE VICE PRESIDENT) |
| NPI Enumeration Date | 11/28/2005 |
Other providers sharing the same authorized official: LAWLESS, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 268,934 | $12.25M |
| 2019 | 293,525 | $13.69M |
| 2020 | 279,954 | $13.68M |
| 2021 | 315,435 | $14.70M |
| 2022 | 327,345 | $18.42M |
| 2023 | 338,434 | $21.34M |
| 2024 | 282,688 | $18.11M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 39,734 | 24,614 | $12.23M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 46,743 | 37,005 | $11.25M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 41,674 | 35,525 | $6.56M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 9,227 | 7,307 | $6.31M |
| 41899 | Unlisted procedure, dentoalveolar structures | 5,808 | 4,821 | $6.12M |
| G0378 | Hospital observation service, per hour | 14,587 | 7,600 | $3.11M |
| 70450 | Computed tomography, head or brain; without contrast material | 11,140 | 8,458 | $2.44M |
| 93458 | 3,298 | 1,265 | $2.16M | |
| 47562 | 1,477 | 819 | $1.75M | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 3,198 | 2,063 | $1.58M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 36,383 | 28,996 | $1.51M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1,471 | 1,162 | $1.51M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,663 | 1,310 | $1.45M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,461 | 3,563 | $1.40M |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 33,450 | 26,501 | $1.38M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 36,021 | 17,298 | $1.21M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 768 | 704 | $1.14M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 18,697 | 8,826 | $1.14M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 5,134 | 3,650 | $1.13M |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1,435 | 1,275 | $1.11M |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 3,489 | 2,661 | $1.08M |
| 71045 | Radiologic examination, chest; single view | 28,193 | 20,575 | $1.03M |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,148 | 2,549 | $1.02M |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,393 | 2,829 | $916K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 2,944 | 2,180 | $902K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 3,388 | 3,082 | $888K |
| 87631 | 10,651 | 9,604 | $856K | |
| G0379 | Direct admission of patient for hospital observation care | 3,189 | 1,589 | $848K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 12,448 | 9,164 | $799K |
| 96375 | Therapeutic injection; each additional sequential IV push | 19,274 | 13,529 | $774K |
| 76830 | Ultrasound, transvaginal | 4,870 | 4,365 | $716K |
| 71046 | Radiologic examination, chest; 2 views | 11,754 | 9,708 | $665K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 9,056 | 8,632 | $660K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 6,060 | 5,308 | $622K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 4,204 | 3,474 | $552K |
| 72141 | 2,317 | 1,989 | $533K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 8,093 | 7,052 | $531K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3,148 | 2,672 | $530K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 106,531 | 78,145 | $523K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 7,830 | 5,341 | $521K |
| 36415 | Collection of venous blood by venipuncture | 147,835 | 76,964 | $516K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 17,057 | 4,643 | $511K |
| 72131 | 2,468 | 2,011 | $507K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 5,358 | 2,477 | $502K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,902 | 1,324 | $498K |
| 71250 | 2,369 | 1,915 | $484K | |
| J7050 | Infusion, normal saline solution, 250 cc | 52,215 | 24,683 | $474K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 1,731 | 1,241 | $473K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 12,293 | 10,735 | $458K |
| 80053 | Comprehensive metabolic panel | 64,939 | 42,962 | $448K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 2,509 | 1,683 | $443K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4,422 | 4,001 | $435K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,650 | 1,457 | $429K |
| 72110 | 3,619 | 3,154 | $427K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 17,998 | 11,353 | $423K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 1,605 | 1,496 | $420K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 1,540 | 1,379 | $393K |
| C1769 | Guide wire | 3,568 | 2,928 | $367K |
| 70486 | 1,517 | 1,338 | $365K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19,840 | 15,987 | $364K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 596 | 516 | $359K |
| 64721 | 589 | 397 | $350K | |
| 93971 | 2,183 | 1,919 | $347K | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 23,977 | 18,774 | $339K |
| 93976 | 2,142 | 1,894 | $335K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 7,007 | 6,282 | $330K |
| J2704 | Injection, propofol, 10 mg | 31,839 | 23,346 | $324K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 39,902 | 29,030 | $312K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 28,823 | 19,487 | $311K |
| 74018 | 4,931 | 4,339 | $309K | |
| 76642 | 3,907 | 3,190 | $307K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2,558 | 2,124 | $306K |
| 76536 | 1,978 | 1,815 | $306K | |
| 93017 | 2,354 | 2,127 | $297K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 9,189 | 7,147 | $275K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 12,859 | 9,488 | $273K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 6,490 | 2,331 | $272K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 10,708 | 3,415 | $252K |
| 73562 | 3,504 | 2,616 | $251K | |
| 58661 | 189 | 111 | $239K | |
| 73221 | 1,091 | 931 | $231K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 1,267 | 1,003 | $229K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 792 | 669 | $227K |
| 80048 | Basic metabolic panel (calcium, ionized) | 47,809 | 33,462 | $225K |
| 72100 | 3,599 | 2,933 | $222K | |
| 76770 | 1,653 | 1,415 | $214K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 17,622 | 10,119 | $213K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 26,405 | 21,444 | $212K |
| 72128 | 975 | 820 | $210K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,727 | 3,403 | $209K |
| 84484 | 25,215 | 18,696 | $208K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 6,085 | 2,250 | $208K |
| 73030 | 3,117 | 2,358 | $205K | |
| 93970 | 980 | 879 | $202K | |
| 72050 | 1,834 | 1,307 | $201K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 7,623 | 2,698 | $197K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 10,105 | 5,691 | $195K |
| 84443 | Thyroid stimulating hormone (TSH) | 16,189 | 14,445 | $195K |
| 94060 | 1,750 | 1,422 | $194K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 2,412 | 1,896 | $192K |
| 75574 | 485 | 403 | $188K | |
| 80306 | 17,948 | 14,951 | $187K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 9,138 | 8,439 | $187K |
| J3490 | Unclassified drugs | 14,490 | 5,485 | $185K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 24,523 | 19,721 | $181K |
| 77386 | 376 | 27 | $177K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 2,914 | 1,919 | $170K |
| 73630 | 2,545 | 2,109 | $169K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7,323 | 6,641 | $168K |
| 77063 | Screening digital breast tomosynthesis, bilateral | 6,777 | 5,453 | $165K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 2,769 | 2,225 | $163K |
| 80061 | Lipid panel | 15,325 | 10,609 | $158K |
| 77066 | Tomosynthesis, mammo | 1,957 | 1,528 | $158K |
| 72040 | 2,349 | 1,834 | $152K | |
| 73130 | 2,116 | 1,747 | $150K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1,746 | 1,524 | $150K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,973 | 2,573 | $149K |
| 77065 | Tomosynthesis, mammo | 2,531 | 2,019 | $146K |
| 73610 | 2,131 | 1,799 | $145K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 15,414 | 9,615 | $144K |
| 76819 | Fetal biophysical profile; without non-stress testing | 816 | 589 | $133K |
| 73502 | 1,991 | 1,415 | $132K | |
| 72072 | 1,633 | 1,280 | $127K | |
| 97161 | 6,004 | 2,677 | $127K | |
| 77080 | 2,026 | 1,452 | $116K | |
| 88342 | 1,947 | 1,660 | $116K | |
| 83880 | 5,178 | 4,267 | $106K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 15,348 | 12,314 | $106K |
| 84703 | 22,421 | 18,967 | $103K | |
| 88307 | 1,424 | 1,105 | $102K | |
| 85730 | 25,225 | 19,697 | $100K | |
| 72052 | 746 | 609 | $99K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 9,106 | 6,764 | $95K |
| 82607 | 8,031 | 7,078 | $95K | |
| 88304 | 4,816 | 4,290 | $90K | |
| 70491 | 270 | 226 | $90K | |
| 73700 | 481 | 412 | $89K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2,314 | 2,124 | $86K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 278 | 264 | $85K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2,693 | 2,447 | $84K |
| 85610 | 31,630 | 24,257 | $82K | |
| J1170 | Injection, hydromorphone, up to 4 mg | 8,447 | 5,374 | $82K |
| 83690 | 18,667 | 15,725 | $79K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 5,946 | 4,094 | $77K |
| 94729 | 1,489 | 1,417 | $77K | |
| 80074 | 2,021 | 1,773 | $72K | |
| 80047 | 6,081 | 5,288 | $72K | |
| 71271 | 1,052 | 799 | $72K | |
| 73110 | 1,102 | 883 | $71K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 11,270 | 9,992 | $71K |
| 77336 | 724 | 241 | $69K | |
| J2785 | Injection, regadenoson, 0.1 mg | 1,175 | 1,079 | $68K |
| 93922 | 624 | 496 | $67K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 3,203 | 2,834 | $67K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,280 | 1,122 | $67K |
| 76870 | 429 | 375 | $67K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 19,228 | 15,129 | $66K |
| 84145 | 4,475 | 3,779 | $65K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 3,165 | 2,825 | $65K |
| A9585 | Injection, gadobutrol, 0.1 ml | 3,047 | 2,570 | $64K |
| C1889 | Implantable/insertable device, not otherwise classified | 431 | 395 | $64K |
| 95816 | 693 | 595 | $63K | |
| 74246 | 517 | 451 | $61K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 883 | 706 | $60K |
| 96376 | 2,431 | 2,059 | $59K | |
| 82565 | 6,384 | 4,214 | $59K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1,410 | 1,326 | $59K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 12,178 | 9,359 | $58K |
| 80076 | 11,576 | 10,037 | $58K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 5,436 | 2,041 | $56K |
| 82728 | 5,460 | 4,705 | $55K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 4,749 | 2,910 | $55K |
| 84112 | 1,008 | 838 | $53K | |
| 94726 | 1,221 | 1,159 | $51K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 309 | 240 | $50K |
| 84702 | 4,937 | 3,853 | $50K | |
| 83735 | 11,578 | 8,349 | $50K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 2,402 | 1,930 | $50K |
| 36600 | 3,732 | 2,148 | $50K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 240 | 216 | $49K |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 7,311 | 2,082 | $49K |
| 94664 | 11,493 | 7,012 | $47K | |
| 81003 | 20,261 | 17,512 | $45K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 2,865 | 2,554 | $44K |
| 49083 | 152 | 66 | $44K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 2,613 | 2,029 | $43K |
| 81001 | 20,071 | 16,758 | $43K | |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 4,126 | 2,246 | $43K |
| 87040 | 4,794 | 3,697 | $43K | |
| C9113 | Injection, pantoprazole sodium, per vial | 4,992 | 2,264 | $42K |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 4,649 | 4,028 | $41K |
| 93880 | 362 | 228 | $41K | |
| G0476 | Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 1,951 | 1,375 | $40K |
| 96367 | 2,728 | 1,032 | $38K | |
| 84439 | 5,245 | 4,665 | $37K | |
| 87486 | 2,326 | 2,078 | $37K | |
| 72156 | 135 | 117 | $36K | |
| 87081 | 8,246 | 7,378 | $36K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 2,054 | 1,772 | $36K |
| 87581 | 2,254 | 2,068 | $35K | |
| 10005 | 121 | 94 | $35K | |
| J1644 | Injection, heparin sodium, per 1000 units | 4,639 | 2,861 | $35K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 1,154 | 1,106 | $34K |
| 82803 | 2,661 | 2,233 | $34K | |
| 82746 | 2,971 | 2,674 | $34K | |
| 97162 | 1,059 | 701 | $34K | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 4,603 | 3,262 | $33K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 1,458 | 1,297 | $32K |
| 95886 | 451 | 392 | $32K | |
| 86850 | 6,651 | 5,368 | $32K | |
| 87522 | Neg quan hep c or qual rna | 793 | 707 | $32K |
| 77334 | 127 | 65 | $32K | |
| 83605 | 4,653 | 3,851 | $31K | |
| 78227 | 71 | 63 | $31K | |
| 93975 | 145 | 125 | $31K | |
| 85379 | 5,144 | 4,547 | $31K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 139 | 124 | $31K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 2,065 | 1,850 | $31K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 3,997 | 3,008 | $30K |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 1,029 | 854 | $30K |
| 95911 | 87 | 78 | $30K | |
| 58563 | 12 | 12 | $29K | |
| 43235 | 143 | 102 | $29K | |
| 85027 | 6,453 | 5,147 | $28K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 2,877 | 2,199 | $28K |
| 76000 | 389 | 290 | $28K | |
| 73080 | 390 | 339 | $28K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 217 | 192 | $26K |
| P9016 | Red blood cells, leukocytes reduced, each unit | 331 | 193 | $26K |
| 81015 | 9,973 | 8,403 | $26K | |
| 90715 | 1,735 | 1,559 | $26K | |
| 42830 | 29 | 25 | $26K | |
| 86900 | 7,333 | 5,809 | $25K | |
| J3370 | Injection, vancomycin hcl, 500 mg | 2,272 | 1,359 | $25K |
| J3475 | Injection, magnesium sulfate, per 500 mg | 2,496 | 1,844 | $25K |
| 87070 | 4,463 | 3,236 | $25K | |
| C1763 | Connective tissue, non-human (includes synthetic) | 19 | 14 | $24K |
| 83540 | 4,843 | 4,412 | $24K | |
| J7699 | Noc drugs, inhalation solution administered through dme | 505 | 466 | $24K |
| 84481 | 1,913 | 1,738 | $24K | |
| 86140 | 6,991 | 5,429 | $23K | |
| 87480 | 1,729 | 1,498 | $23K | |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 724 | 180 | $23K |
| 87186 | 3,787 | 3,248 | $23K | |
| 44970 | 15 | 12 | $23K | |
| 72158 | 90 | 73 | $23K | |
| 96415 | 644 | 391 | $23K | |
| 83550 | 3,575 | 3,262 | $23K | |
| J3480 | Injection, potassium chloride, per 2 meq | 1,785 | 923 | $22K |
| 73590 | 390 | 277 | $22K | |
| 90834 | Psychotherapy, 45 minutes with patient | 1,512 | 1,003 | $22K |
| 97116 | 1,237 | 463 | $21K | |
| 84425 | 1,336 | 1,215 | $21K | |
| 88142 | 1,172 | 1,116 | $21K | |
| 87510 | 1,651 | 1,488 | $21K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 389 | 213 | $21K |
| 82375 | 2,747 | 2,309 | $20K | |
| D9420 | 162 | 107 | $20K | |
| 87660 | 1,650 | 1,487 | $20K | |
| 86920 | 373 | 250 | $19K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 2,028 | 1,687 | $19K |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 2,315 | 1,515 | $19K |
| 73090 | 363 | 291 | $18K | |
| D4341 | 78 | 38 | $18K | |
| 0352U | 221 | 210 | $18K | |
| M0245 | Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring | 63 | 61 | $18K |
| G0475 | Hiv antigen/antibody, combination assay, screening | 811 | 731 | $18K |
| 77300 | 72 | 24 | $18K | |
| 70498 | 64 | 50 | $18K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 79 | 52 | $17K |
| 82150 | 4,313 | 3,710 | $17K | |
| C1874 | Stent, coated/covered, with delivery system | 20 | 12 | $17K |
| 86803 | 1,396 | 1,236 | $16K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,147 | 974 | $15K |
| 86901 | 8,423 | 6,840 | $15K | |
| 87088 | 2,613 | 2,260 | $14K | |
| 82550 | 3,175 | 2,119 | $14K | |
| J1453 | Injection, fosaprepitant, 1 mg | 162 | 99 | $14K |
| 59025 | Fetal non-stress test | 174 | 139 | $14K |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,994 | 1,546 | $14K |
| 82731 | 325 | 266 | $13K | |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 633 | 398 | $13K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 172 | 159 | $13K |
| 87075 | 1,913 | 1,564 | $13K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 670 | 330 | $13K |
| 96417 | 528 | 280 | $12K | |
| 92526 | 398 | 137 | $12K | |
| 97164 | 468 | 395 | $12K | |
| 85651 | 4,598 | 3,468 | $12K | |
| 74178 | 25 | 12 | $12K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 837 | 272 | $11K |
| C1729 | Catheter, drainage | 325 | 176 | $11K |
| 84132 | 3,996 | 3,345 | $11K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,246 | 1,050 | $11K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 195 | 165 | $11K |
| 84100 | 2,983 | 2,388 | $11K | |
| 97535 | Self-care/home management training, each 15 minutes | 802 | 452 | $11K |
| 86780 | 1,026 | 953 | $11K | |
| 72082 | 99 | 81 | $11K | |
| 84134 | 1,091 | 914 | $11K | |
| 86592 | 2,942 | 2,430 | $11K | |
| J1756 | Injection, iron sucrose, 1 mg | 197 | 71 | $11K |
| 83921 | 671 | 624 | $11K | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,169 | 1,195 | $10K |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | 81 | 71 | $10K |
| 87077 | 1,545 | 1,334 | $10K | |
| 87205 | 3,132 | 2,504 | $10K | |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 1,292 | 1,002 | $10K |
| A6213 | Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing | 1,250 | 681 | $10K |
| 88312 | 656 | 597 | $10K | |
| 74230 | 127 | 77 | $10K | |
| 83001 | 612 | 569 | $9K | |
| 87507 | 46 | 40 | $9K | |
| 82553 | 1,112 | 759 | $9K | |
| 76942 | 87 | 83 | $9K | |
| 82570 | 2,215 | 1,922 | $9K | |
| 84597 | 644 | 604 | $9K | |
| 84403 | 436 | 400 | $9K | |
| A4565 | Slings | 389 | 311 | $9K |
| 36430 | 150 | 105 | $8K | |
| 97165 | 277 | 207 | $8K | |
| 74022 | 105 | 84 | $8K | |
| J3411 | Injection, thiamine hcl, 100 mg | 749 | 494 | $8K |
| 86481 | 81 | 79 | $8K | |
| 83050 | 1,516 | 1,265 | $8K | |
| 84446 | 754 | 698 | $7K | |
| 10022 | 36 | 28 | $7K | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 1,304 | 1,102 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 237 | 219 | $7K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 24 | 14 | $7K |
| 72146 | 44 | 37 | $7K | |
| 88172 | 119 | 114 | $7K | |
| 83615 | 1,658 | 1,356 | $6K | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 885 | 593 | $6K |
| 95819 | 77 | 66 | $6K | |
| 88341 | 106 | 89 | $6K | |
| 83883 | 479 | 243 | $6K | |
| 76376 | 81 | 65 | $6K | |
| 84590 | 671 | 630 | $6K | |
| 83516 | 410 | 245 | $6K | |
| 86038 | 614 | 559 | $6K | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 34 | 33 | $6K |
| 86762 | 561 | 497 | $6K | |
| 82043 | 1,126 | 970 | $6K | |
| 82140 | 668 | 516 | $6K | |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 605 | 290 | $6K |
| 80323 | 72 | 31 | $5K | |
| 95012 | 101 | 96 | $5K | |
| 75635 | 20 | 13 | $5K | |
| 76882 | 53 | 44 | $5K | |
| 82542 | 35 | 34 | $5K | |
| 84146 | 371 | 328 | $5K | |
| C1781 | Mesh (implantable) | 15 | 14 | $5K |
| J7999 | Compounded drug, not otherwise classified | 894 | 716 | $5K |
| 12002 | 107 | 93 | $5K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 35 | 31 | $5K |
| J1940 | Injection, furosemide, up to 20 mg | 694 | 335 | $5K |
| J1630 | Injection, haloperidol, up to 5 mg | 622 | 505 | $5K |
| D0150 | Comprehensive oral evaluation - new or established patient | 45 | 26 | $5K |
| 85018 | 3,549 | 2,715 | $4K | |
| 12001 | 132 | 120 | $4K | |
| 64415 | 23 | 16 | $4K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 120 | 89 | $4K |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 67 | 59 | $4K |
| 95957 | 314 | 264 | $4K | |
| 94727 | 120 | 113 | $4K | |
| 84550 | 1,250 | 1,028 | $4K | |
| 72157 | 16 | 13 | $4K | |
| 86003 | 68 | 37 | $4K | |
| 97012 | 215 | 83 | $4K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 309 | 195 | $4K |
| 71101 | 45 | 39 | $3K | |
| 90832 | Psychotherapy, 30 minutes with patient | 88 | 67 | $3K |
| 73521 | 43 | 41 | $3K | |
| 82670 | 136 | 121 | $3K | |
| 73140 | 39 | 36 | $3K | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 93 | 88 | $3K |
| 84165 | 455 | 413 | $3K | |
| 83002 | 211 | 198 | $3K | |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 369 | 205 | $3K |
| 86787 | 302 | 266 | $3K | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 628 | 488 | $3K |
| D0210 | Intraoral - complete series of radiographic images | 26 | 13 | $3K |
| 93925 | 13 | 12 | $3K | |
| 94761 | 186 | 126 | $3K | |
| J2305 | Injection, nitroglycerin, 5 mg | 346 | 298 | $3K |
| A4648 | Tissue marker, implantable, any type, each | 37 | 26 | $3K |
| 86694 | 248 | 152 | $3K | |
| 80352 | 72 | 30 | $3K | |
| J0780 | Injection, prochlorperazine, up to 10 mg | 236 | 199 | $3K |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 33 | 24 | $3K |
| 82105 | 180 | 163 | $2K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 350 | 251 | $2K |
| 84156 | 918 | 716 | $2K | |
| 80177 | 250 | 212 | $2K | |
| 77280 | 62 | 12 | $2K | |
| 0097U | 15 | 12 | $2K | |
| J1953 | Injection, levetiracetam, 10 mg | 117 | 80 | $2K |
| 88108 | 139 | 94 | $2K | |
| 88302 | 202 | 140 | $2K | |
| 85014 | 1,545 | 1,050 | $2K | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 191 | 101 | $2K |
| 82784 | 196 | 109 | $2K | |
| 84480 | 165 | 157 | $2K | |
| L3908 | Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf | 108 | 98 | $2K |
| 80164 | 183 | 144 | $2K | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 82 | 50 | $2K |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 511 | 293 | $2K |
| 82977 | 119 | 105 | $2K | |
| 12011 | 38 | 37 | $2K | |
| J2805 | Injection, sincalide, 5 micrograms | 52 | 50 | $2K |
| 80355 | 72 | 30 | $2K | |
| 82010 | 304 | 265 | $2K | |
| 73060 | 15 | 13 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 217 | 197 | $1K |
| 74019 | 27 | 26 | $1K | |
| J1171 | Injection, hydromorphone, 0.1 mg | 262 | 128 | $1K |
| 93246 | 21 | 19 | $1K | |
| 83009 | 29 | 28 | $1K | |
| 94762 | 50 | 38 | $1K | |
| 82950 | 348 | 282 | $1K | |
| L3670 | Shoulder orthosis, acromio/clavicular (canvas and webbing type), prefabricated, off-the-shelf | 16 | 12 | $1K |
| 10060 | 12 | 12 | $1K | |
| 87045 | 172 | 151 | $1K | |
| 84153 | 87 | 85 | $1K | |
| 83698 | 36 | 35 | $1K | |
| 0353U | 30 | 27 | $1K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 155 | 138 | $1K |
| 80354 | 40 | 40 | $1K | |
| 89051 | 174 | 100 | $1K | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 76 | 66 | $996.40 |
| 88313 | 28 | 25 | $996.39 | |
| 29125 | 12 | 12 | $929.02 | |
| 73560 | 29 | 24 | $904.67 | |
| 82248 | 195 | 119 | $886.03 | |
| 72070 | 21 | 13 | $726.80 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 57 | 27 | $719.62 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 61 | 26 | $712.06 |
| 84155 | 399 | 356 | $685.07 | |
| 88311 | 62 | 49 | $678.37 | |
| 73552 | 14 | 13 | $672.88 | |
| 97163 | 16 | 12 | $662.20 | |
| 84207 | 27 | 27 | $639.86 | |
| J7614 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg | 65 | 47 | $610.13 |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 166 | 145 | $598.45 |
| A6223 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size more than 16 sq. in., but less than or equal to 48 sq. in., without adhesive border, each dressing | 249 | 210 | $570.30 |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 12 | 12 | $559.91 |
| 0031A | 16 | 16 | $531.18 | |
| 84681 | 37 | 36 | $530.70 | |
| 84144 | 29 | 26 | $462.26 | |
| A6222 | Gauze, impregnated with other than water, normal saline, or hydrogel, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | 187 | 159 | $444.60 |
| 72170 | 15 | 12 | $432.15 | |
| 82785 | 16 | 12 | $419.28 | |
| 85384 | 73 | 56 | $416.11 | |
| 96158 | 12 | 12 | $407.30 | |
| 83525 | 53 | 48 | $393.21 | |
| 83695 | 38 | 37 | $391.22 | |
| 82330 | 29 | 28 | $381.01 | |
| 82652 | 15 | 13 | $379.25 | |
| 86141 | 36 | 35 | $376.53 | |
| 83655 | 29 | 29 | $373.28 | |
| 82247 | 82 | 50 | $354.44 | |
| 84450 | 75 | 64 | $346.07 | |
| 86308 | 104 | 93 | $335.02 | |
| 83970 | 12 | 12 | $329.42 | |
| G0008 | Administration of influenza virus vaccine | 37 | 32 | $321.97 |
| 84460 | 64 | 53 | $309.72 | |
| 84630 | 29 | 25 | $269.74 | |
| 87641 | 13 | 13 | $265.92 | |
| 82378 | 16 | 13 | $255.53 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 14 | 12 | $253.29 |
| L4387 | Walking boot, non-pneumatic, with or without joints, with or without interface material, prefabricated, off-the-shelf | 13 | 12 | $237.36 |
| 80069 | 50 | 27 | $224.09 | |
| 90791 | Psychiatric diagnostic evaluation | 15 | 12 | $219.31 |
| 84160 | 54 | 46 | $217.97 | |
| 96156 | 12 | 12 | $215.78 | |
| 86708 | 13 | 12 | $212.97 | |
| 82947 | 127 | 86 | $208.57 | |
| J1956 | Injection, levofloxacin, 250 mg | 34 | 25 | $204.84 |
| 86431 | 41 | 39 | $202.59 | |
| 82525 | 14 | 14 | $198.66 | |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 422 | 282 | $195.73 |
| 85347 | 39 | 26 | $147.68 | |
| 84295 | 57 | 52 | $136.20 | |
| 87015 | 27 | 25 | $117.60 | |
| 87206 | 27 | 25 | $116.67 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 12 | 12 | $112.81 |
| 87102 | 13 | 12 | $104.76 | |
| 83718 | 12 | 12 | $80.45 | |
| 82435 | 15 | 15 | $52.85 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 414 | 304 | $51.98 |
| 82465 | 13 | 13 | $43.69 | |
| 3044F | 124 | 91 | $31.80 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 12 | 12 | $20.09 |
| 84520 | 13 | 12 | $19.87 | |
| 3046F | 22 | 13 | $14.46 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 77 | 71 | $0.00 |